Wuhan Landmark Industral

You are here: HomeProducts3,4,5-Trimethoxycinnamic acid sd

Contact us

  • Company Name: Wuhan Landmark Industral
  • Country/region: China
  • Contact Person: Mr.Oscar Nmk
  • Tel: 86-027-18062528903
  • Email:

3,4,5-Trimethoxycinnamic acid sd

  • CAS No:90-50-6 3,4,5-Trimethoxycinnamic acid
    Molecular Structure

    Detailed Description

    Storage method: Avoid fire and direct sunlight, sealed stored in cool place.
    Usage :
    Improve the surface adhesion of organic and inorganic materials.
    2.Pharmaceutical intermediates, largely used in cinepazide.
    3.This product is mainly used to improve the adhesion properties of organic and inorganic materials, such as the treatment of glass fiber in glass fiber and plastic, rubber, paint, silicon filler in coatings and other materials, and also used in adhesives to increase Adhesive properties, the resin it is suitable for include epoxy, phenolic, melamine, polysulfide polyurethane, polystyrene, etc.
    A).Improve the adhesion of inorganic fillers, substrates and resins, so as to improve the mechanical strength and electrical properties of composite materials, and have a higher retention rate in the wet state.
    B).As a surface treatment agent for inorganic fillers, this product is widely used in clay, talc, wollastonite, white carbon black, quartz, aluminum powder, iron powder.
    C). This product is used for epoxy sealant filled with quartz, epoxy concrete repair material or coating filled with sand grains, and epoxy mold material filled with metal.
    D).This product can also improve the adhesion of two-component epoxy sealants. Improve the adhesion of acrylic latex, sealant, polyurethane, epoxy coating.
    E).3,4,5-trimethoxycinnamic acid can also be used in the production of cardiovascular and cerebrovascular drugs, which has a significant prevention and treatment effect on patients
    3,4,5-trimethoxycinnamic acid has extremely significant curative effects on medicines for preventing and treating cardiovascular and cerebrovascular diseases.